Antibiotic susceptibility testing (Agar disk diffusion and agar dilution) of clinical isolates of Corynebacterium jeikeium

Chemotherapy

Volumn 44, Issue 4, 1998, Pages 230-237

  Traub, Walter H ^a   Geipel, Udo ^a   Leonhard, Birgit ^a   Bauer, Dierk ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Agar dilution test; Agar disk diffusion (Bauer Kirby) test; Antibiotic susceptibility; Corynebacterium jeikeium; Minimal inhibitory concentrations; Mueller Hinton agar; Wilkins Chalgren agar

Indexed keywords

AGAR; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIINFECTIVE AGENT; CEFEPIME; CEFIXIME; CEFOTAXIME; CEFUROXIME; CHLORAMPHENICOL; CIPROFLOXACIN; CLARITHROMYCIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; FOSFOMYCIN; FUSIDIC ACID; IMIPENEM; MEROPENEM; NITROFURANTOIN; OFLOXACIN; OXACILLIN; PENICILLIN G; PIPERACILLIN; PSEUDOMONIC ACID; RIFAMPICIN; SULTAMICILLIN; TEICOPLANIN; TETRACYCLINE; VANCOMYCIN;

AGAR GEL DIFFUSION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; CORYNEBACTERIUM; INTERMETHOD COMPARISON; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

AGAR; ANTI-BACTERIAL AGENTS; CORYNEBACTERIUM; CULTURE MEDIA; DRUG RESISTANCE, MICROBIAL; ENTEROCOCCUS; EVALUATION STUDIES; HUMANS; MICROBIAL SENSITIVITY TESTS; MICROBIOLOGICAL TECHNIQUES;

EID: 0031779781     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000007119     Document Type: Article

References (59)

1. Johnson WD, Kaye D: Serious infections caused by diphtheroids. Ann NY Acad Sci 1970;174:569-576.
2. Hande KR, Witebsky FG, Brown MS, Shulman CB, Anderson SE, Levine AS, MacLowry JD, Chabner BA: Sepsis with a new species of corynebacterium. Ann Intern Med 1976;85:423-426.
3. Riley PS, Hollis DG, Utter GB, Weaver RE, Baker CN: Characterization and identification of 95 diphtheroid (group JK) cultures isolated from clinical specimens. J Clin Microbiol 1979;9:418-424.
4. Gill VJ, Manning C, Lamson M, Woltering P, Pizzo PA: Antibiotic-resistant group JK bacteria in hospitals. J Clin Microbiol 1981;12:472-477.
5. McGowan JE: JK coryneforms: A continuing problem for hospital infection control. J Hosp Infect 1988; 11(suppl A):358-366.
6. Coyle MB, Lipsky BA: Coryneform bacteria in infectious diseases: Clinical and laboratory aspects. Clin Microbiol Rev 1990;3:227-246.
7. Lipsky BA, Goldberger AC, Tompkins LS, Plorde JJ: Infections caused by nondiphtheria corynebacteria. Rev Infect Dis 1982;4:1220-1235.
8. Funke G, von Graevenitz A, Clarridge JE, Bernard KA: Clinical microbiology of coryneform bacteria. Clin Microbiol Rev 1997;10:125-159.
9. Stamm WE, Tompkins LS, Wagner KF, Counts GW, Thomas ED, Meyers JD: Infection due to Corynebacterium species in marrow transplant patients. Ann Intern Med 1979;91:167-173.
10. Finger H, Wirsing von Koenig CH, Wichmann S, Becker-Boost E, Drechsler HJ: Clinical significance of resistant corynebacteria group JK. Lancet 1983;i:538.
11. Allen KD, Green HT: Infections due to a 'group JK' Corynebacterium. J Infect Dis 1986;13:41-44.
12. Dibb WL, von der Lippe E: Septicemia in granulocytic patients caused by multiresistant diphtheroid rods. Acta Pathol Microbiol Scand 1984;892:181-182.
13. Pierard D, Lauwers S, Mouton MC, Sennesael J, Verbeden D: Group JK Corynebacterium peritonitis in a patient undergoing continuous ambulatory peritoneal dialysis. J Clin Microbiol 1983;18:1011-1014.
14. Pearson TA, Braine HG, Rathburn HK: Corynebacterium sepsis in oncology patients: Predisposing factors, diagnosis, and treatment. JAMA 1977;238:1737-1740.
15. Riebel W, Frantz N, Adelstein D, Spagnuolo PJ: Corynebacterium JK: A cause of nosocomial device-related infection. Rev Infect Dis 1986;8: 42-49.
16. Murray BE, Karchmer AW, Moellering RC: Diphtheroid prosthetic valve endocarditis: A study of clinical features and infecting organisms. Am J Med 1980;69:838-848.
17. Young VM, Meyers WF, Moody MR, Schimpff SC: The emergence of coryneform bacteria as a cause of nosocomial infection in compromised hosts. Am J Med 1981;70: 646-650.
18. Greene KA, Clark RJ, Zabramski JM: Ventricular CSF shunt infections associated with Corynebacterium jeikeium: Report of three cases and review. Clin Infect Dis 1993;16: 139-141.
19. Hoffman S, Ersgaard H, Justesen T, Friis H: Fatal meningitis with group JK Corynebacterium in a leucopenic patient. Eur J Clin Microbiol 1983;2:213-215.
20. Kerry-Williams SM, Noble WC: Group JK coryneform bacteria. J Hosp Infect 1987;9:4-10.
21. Spach DH, Opp DR, Gabre-Kidan T: Bacteremia due to Corynebacterium jeikeium in a patient with AIDS. Rev Infect Dis 1991;13:342-343.
22. Turett GS, Fazal BA, Johnston BE, Telzak EE: Liver abscess due to Corynebacterium jeikeium in a patient with AIDS. Clin Infect Dis 1993;17: 514-515.
23. Wichmann S, Wirsing von Koenig CH, Becker-Boost E, Finger H: Group JK corynebacteria in skin flora of healthy persons and patients. Eur J Clin Microbiol 1985;4:502-504.
24. Larson EL, McGinley KJ, Leyden JJ, Cooley ME, Talbot GH: Skin colonization with antibiotic-resistant (JK group) and antibiotic-sensitive lipophilic diphtheroids in hospitalized and normal adults. J Infect Dis 1986;153:701-706.
25. Soriano F, Rodriguez-Tudela JL, Fernandez-Roblas R, Aguado JM, Santamaria M: Skin colonization by Corynebacterium groups D2 and JK in hospitalized patients. J Clin Microbiol 1988;26:1878-1880.
26. Telander B, Lerner R, Palmblad J, Ringertz O: Corynebacterium group JK in a hematological ward: Infections, colonization and environmental contamination. Scand J Infect Dis 1988;20:55-61.
27. McGinley K, Labows JN, Zechman JM, Nordstrom KM, Webster GF, Leyden JJ: Pathogenic JK group corynebacteria and their similarity to human cutaneous lipophilic diphtheroids. J Infect Dis 1985;152:801-806.
28. Jackman PJH, Pitcher DG, Pelczynska S, Borman P: Classification of corynebacteria associated with endocarditis (group JK) as Corynebacterium jeikeium sp. nov. Syst Appl Microbiol 1987;9:83-90.
29. Riegel P, de Briel D, Prevost G, Jehl F, Monteil H: Genomic diversity among Corynebacterium jeikeium strains and comparison with biochemical characteristics and antimicrobial susceptibilities. J Clin Microbiol 1994;32:1860-1865.
30. McNaughton RD, Villanueva RR, Donnelly R, Freedman J, Nawrot R: Cavitating pneumonia caused by Corynebacterium group JK. J Clin Microbiol 1988;26:2216-2217.
31. Vanbosterhaut B, Surmont I, Vandeven J, Wauters G, Vandepitte J: Corynebacterium jeikeium (group JK diphtheroids) endocarditis. A report of five cases. Diagn Microbiol Infect Dis 1989;12:265-268.
32. Waters BL: Pathology of culture-proven JK Corynebacterium pneumonia. Am J Clin Pathol 1989;91: 616-619.
33. Dan M, Somer I, Knobel B, Gutman R: Cutaneous manifestations of infection with Corynebacterium group JK. Rev Infect Dis 1988;10:1204-1207.
34. Guarino MJ, Qazi R, Woll JE, Rubins J: Septicemia, rash, and pulmonary infiltrates secondary to corynebacterium group JK infection. Am J Med 1987;82:132-134.
35. Cartwright CP, Stock F, Kruczak-Filipov PM, Gill VJ: Rapid method for presumptive identification of Corynebacterium jeikeium. J Clin Microbiol 1993;31:3320-3322.
36. Quinn JPO, Arnow PM, Weil D, Rosenbluth J: Outbreak of JK diphtheroid infections associated with environmental contamination. J Clin Microbiol 1984;19:668-671.
37. Pitcher D, Johnson A, Allerberger F, Woodford N, George R: An investigation of nosocomial infection with Corynebacterium jeikeium in surgical patients using a ribosomal RNA gene probe. Eur J Clin Microbiol Infect Dis 1990;9:643-648.
38. Khabbaz RF, Kaper JB, Moody MR, Schimpff SC, Tenney JH: Molecular epidemiology of group JK corynebacterium on a cancer ward: Lack of evidence for patient-to-patient transmission. J Infect Dis 1986;154:95-99.
39. Lewis R: Antiseptic resistance in JK and other coryneforms. J Hosp Infect 1988;11:150-154.
40. Traub WH: Multiple drug-resistant Corynebacteriaceae: In vitro and in vivo (murine) studies. Chemotherapy 1985;31:372-382.
41. National Committee for Clinical Laboratory Standards: Performance Standards for Antimicrobial Disk Susceptibility Tests, ed 6. NCCLS Document M2-A6. Villanova, NCCLS, 1997.
42. National Committee for Clinical Laboratory Standards: Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically, ed 3. NCCLS Document M7-A3. Villanova, NCCLS, 1993.
43. Clarridge JE, Spiegel CA: Corynebacterium and miscellaneous irregular Gram-positive rods, Erysipelothrix, and Gardnerella; in Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH (eds): Manual of Clinical Microbiology, ed 6. Washington, American Society for Microbiology, 1995, pp 357-378.
44. Bauer AW, Kirby WMM, Sherris JC, Turck M: Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 1966;45:493-496.
45. Traub WH, Spohr M: Fosfomycin: Interpretation of inhibition zones obtained with the Bauer-Kirby agar disk diffusion susceptibility test. Chemotherapy 1983;29:208-212.
46. Finlay JE, Miller LA, Poupard JA: Interpretive criteria for testing susceptibility of staphylococci to mupirocin. Antimicrob Agents Chemother 1997;41:1137-1139.
47. Barry AL, Thornsberry C, Jones RN, Fuchs PC, Gavan TL, Gorbach EH: Reassessment of the 'class' concept of disk susceptibility testing. Cephalothin disks versus minimal inhibitory concentrations with eleven cephalosporins. Am J Clin Pathol 1978;70:909-913.
48. Traub WH, Kohl K-H, Spohr M: In vitro activity of three fluoroquinolones against enterococci and Pseudomonas aeruginosa: Modified categorization system for discrepant broth dilution and agar disk diffusion test results. Chemotherapy 1988;34:101-106.
49. Pennekamp A, Pünter V, Zbinden R: Disk diffusion, agar dilution and the E-test for susceptibility testing of Corynebacterium jeikeium. Clin Microbiol Infect 1996;2:209-213.
50. Dealler SF: In-vitro activity of LY146032 daptomycin and other agents against JK diphtheroids. J Antimicrob Chemother 1988;21: 807-812.
51. Rauturier M, Darbas H, Jean-Pierre H, Boyer G, Riviere M: Vitesses de bactericidie chez les corynebacteries JK et D2 multiresistantes. Pathol Biol 1990;38:420-425.
52. Arora MK, Robbins MJ, Holton J, Felmingham D: In vitro activity of the streptogramin group of antimicrobials against Corynebacterium jeikeium and D2 coryneform bacteria. J Antimicrob Chemother 1989; 23:458-459.
53. Moore LS, Schneider B, Holloway WJ: Minimal inhibitory concentrations and minimal bactericidal concentrations of quinupristin/dalfopristin against clinical isolates of Corynebacterium jeikeium and Listeria monocytogenes. J Antimicrob Chemother 1997;39(suppl A):67-68.
54. Philippon A, Bimet F: In vitro susceptibility of Corynebacterium group D2 and Corynebacterium jeikeium to twelve antibiotics. Eur J Clin Microbiol Infect Dis 1990;9: 892-895.
55. Hohl P, Felber AM: In vitro activity of fleroxacin against aerobic Gram-positive bacteria including Corynebacterium jeikeium. Chemotherapy 1990;36:403-406.
56. Machka K, Balg M: In vitro activity of ciprofloxacin against group JK corynebacteria. Eur J Clin Microbiol 1984;3:375.
57. Rolston KVI, Bodey GP: In vitro activity of various new antimicrobial agents against group JK corynebacteria. Eur J Clin Microbiol 1987; 6:491-492.
58. Venezio FR, Tatarowicz W, DiVincenzo CA, O'Keefe JP: Activity of ciprofloxacin against multiply resistant strains of Pseudomonas aeruginosa, Staphylococcus epidermidis, and group JK corynebacteria. Antimicrob Agents Chemother 1986; 30:940-941.
59. Murphy PG, Ferguson WP: Corynebacterium jeikeium (group JK) resistance to ciprofloxacin emerging during therapy. J Antimicrob Chemother 1987;20:922-923.